Natalie Grover Archives - UNC Lineberger

66th ASH Annual Meeting and Exposition. December 7-10, 2024 in San Diego, California.

Nearly two dozen UNC faculty members and trainees will present research and participate in scientific symposia and educational sessions at the ASH Annual Meeting.

John Bell in his hospital room, wearing a patient gown and gesturing with two thumbs up.

When standard treatment didn’t work to treat his diffuse large B-cell lymphoma, John Bell found successful treatment with CAR-T therapy.

65th ASH Annual Meeting and Exposition, December 9-12, 2023 in San Diego, California.

Researchers from UNC Lineberger and UNC will present findings from studies, speak at scientific symposia and lead educational sessions at the 65th American Society of Hematology Annual Meeting.

Illustrated graphic of a scope target on a cell at a micro level.

CAR-T immunotherapy uses your body’s own immune system to help fight cancer. Jonathan Serody, MD, and Natalie Grover, MD, answer some common questions people have about this treatment.

UNC Lineberger's annual scientific retreat brought together faculty, staff and trainees to learn about the latest research at the cancer center.

As part of a study led by Matthew Foster, MD, the advance was seen in a patient enrolled in a clinical trial using CAR-T to treat refractory acute B-cell leukemia.

UNC Lineberger’s Christopher Dittus, DO, MPH, assistant professor of medicine at UNC School of Medicine, is the editor of a new book that provides a comprehensive review of how to diagnose and manage rare lymphomas, with a focus on novel treatment approaches. UNC Lineberger faculty and trainees contributed chapters to the volume. “Novel Therapeutics for …

Natalie Grover, MD, and Barbara Savoldo, MD

At the 60th American Society of Hematology Annual Meeting in San Diego on Monday, UNC Lineberger's Natalie Grover, MD, presented preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.

Tag: Natalie Grover

UNC researchers presenting research advances at American Society of Hematology annual meeting

WISH: Health Spotlight | Last chance: CAR T-cell therapy gives lymphoma patients another chance

WGEM: Last chance: How CAR T-Cell therapy saved John

CAR-T therapy helps patient beat cancer

UNC researchers present latest findings at American Society of Hematology Annual Meeting

Questions and answers about CAR-T therapy

Scientific retreat underscores impact and promise of cancer center’s research

Engineered safety switch curbs severe side effects of CAR-T immunotherapy

Dittus and colleagues write the book on rare lymphomas

Study shows promise for fighting relapsed blood cancer with CAR-T immunotherapy, chemotherapy